Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease academic.oup.com/europace/ar…
Elijah Behr retweeted
#Epeeps #europace
🤔Are there distinct patterns of ventricular fibrillation onset❓
👉Chek these data from a large data set of primary electrical diseases
Share your experience❗️
🔗doi.org/10.1093/europace/eua…
@GiulioConte9 @FraSantoroMD @marcovitoloMD @AndyZhangMD @Dominik_Linz
Elijah Behr retweeted
🚨#BHRSymposium returns this autumn!
🗓️Thurs 27 Nov |📍@RCPhysicians
Join us for:
💥Debates
💬Interactive discussions
⚡Quick-fire scenarios
🎓High-quality education for all involved in arrhythmia care
🌟Incredible faculty
🎟️Register now:
👉 millbrook-events.co.uk/event…
Elijah Behr retweeted
Back from the Together VT conference in Nuremberg. Discussions so good that I almost missed my train. Kudos @EPDeneke for hosting this year's edition. BTW hands down the best EP conference bag yet
Elijah Behr retweeted
Cardiovascular disease (CVD) causes more than a quarter of UK deaths. Continued support for research is critical.
I joined more than 60 @TheBHF funded-researchers in writing to the Government urging them to prioritise CVD in the Life Sciences Plan bhf.org.uk/what-we-do/news-f…
Elijah Behr retweeted
#CircatHRS25 subcutaneous implantable cardioverter-defibrillator (S-ICD) is superior to the transvenous ICD (TV-ICD) w/ respect to device-related complications during long-term follow-up & should be considered in all patients w/o an indication of pacing. ahajrnls.org/3YMmecU
Elijah Behr retweeted
Are you a cardiology trainee who wishes to research and gain invaluable experience in the field of #SportsCardiology #screening #InheritedCardiacConditions #CardiacImaging to gain an MD/PhD? Then apply for a post @CityStG_Health sponsored by @CRY_UK jobs.sgul.ac.uk/112-25
Elijah Behr retweeted
Also, #EHRA_ESC Consensus on Pharmacological Provocation Testing was presented during #EHRA2025 chaired by @BehrElijah & @JacobTfelt, offering expert guidance on arrhythmic syndromes & SCD/SCA risk ⚡
It covers:
🧪 Na⁺ channel blockers
💉 Epinephrine, adenosine & ergonovine
🔑 Highlights:
✔️ Type 1 Brugada ECG in V1/V2 = positive Ajmaline test
🚫 No routine testing in asymptomatic type 2/3
👉bit.ly/4ckfjxg
#EHRAtopicweek
Elijah Behr retweeted
Great case presentation of a young performer with arrhythmogenic cardiomyopathy presented by @MihneaCasian #ESCPrev2025 highlighting the challenges we face with managing the condition and exercise prescription. @SSharmacardio @RJurcut
Elijah Behr retweeted
The clinical consensus statement on the diagnostic role of pharmacological provocation testing in cardiac #electrophysiology has just been published.
@DrCherylTeresEP discusses with document authors @BehrElijah and @JacobTfelt the key points of the document.
Watch their #EHRAsnacks
#EHRA_ESC #EHRA2025 #EPeeps #pharmacotherapy
Elijah Behr retweeted
📣New Consensus is out in #Europace
#EHRA2025
💊The diagnostic role of pharmacological provocation testing in cardiac electrophysiology💥
🔗 doi.org/10.1093/europace/eua…
@GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @DavideMei93 @marcovitoloMD @LuigiDiBiaseMD
diagnostic role of pharmacological provocation testing in cardiac electrophysiology. A clinical consensus statement of the European Heart Rhythm Association (EHRA) academic.oup.com/europace/ar…
For the diagnosis of #brugadasyndrome #CPVT #WPW #coronaryvasospasm in SCA and sudden death prevention with @JacobTfelt and colleagues
Elijah Behr retweeted
#CRYResearch Influence of age and sex on the diagnostic yield of inherited cardiac conditions in sudden arrhythmic death syndrome decedents #YSCD
The aim was to investigate the impact of age & sex on the overall diagnostic yield & underlying aetiology in decedents with SADS using a combined approach of familial evaluation (FE) and molecular autopsy (MA).
@MichaelPapadak2 @BehrElijah @Spapatheodorou @Drhariraju @Gherardobis @DrAneilMalhotra @CryCardiac @Ssharmacardio
academic.oup.com/eurjpc/adva…
Elijah Behr retweeted
Current guidelines for primary prev ICD might not apply to contemporary pts given advances in HF Rx. Or do they?
🌟 This joint publication in #JCF & @hrs_journal summarizes data to date and proposes clinical trial to reassess.
🔗 bit.ly/3CEUj7a
Elijah Behr retweeted
#Europace #Epeeps 📚
Prognostic relevance of baseline exercise stress test in RYR2-related CPVT 🏃🧬💔
Read more 🔗 academic.oup.com/europace/ar…
@GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD @LuigiDiBiaseMD @DeniKukavica @SilviaPriori1 @amazzanti79
Elijah Behr retweeted
#CRYResearch Influence of age and sex on the diagnostic yield of inherited cardiac conditions in sudden arrhythmic death syndrome decedents #YSCD
@MichaelPapadak2 @BehrElijah @SPapatheodorou @gherardobis @CryCardiac @SSharmacardio
academic.oup.com/eurjpc/adva…
Elijah Behr retweeted
🚨 Great news!
The Late-Breaking Clinical Trial (LBCT) submission deadline for EHRA 2025 has been extended to Thursday, 30 January 2025 (23:59 CET)! ⏳
Don't miss this chance to showcase your groundbreaking research!
#EHRA2025 #LBCT @EHRAPresident @SteliosTzeis
Last chance for fantastic opportunity in cardiac ion channel disease - Lecturer in Cardiovascular Sciences jobs.sgul.ac.uk/108-24-R
Exciting opportunity for @TheBHF funded Bioinformatician/Statistician to work in @GenomicsEngland WGS data on #arrhythmias with the #RASE Consortium @StGeorgesUni @MartaFutema @bhfcrc @roddywalsh jobs.sgul.ac.uk/Vacancy.aspx…



























